Vaccine Day 2010 | Johns Hopkins Vaccine Initiative

Dr. Plotkin

On October 29th, 2010, the Johns Hopkins Vaccine Initiative (JHVI) hosted the third annual Vaccine Day at the Johns Hopkins Bloomberg School of Public Health and were pleased to host special guest, Dr. Stanley Plotkin, Emeritus Professor of the Wistar Institute and Professor, Johns Hopkins Bloomberg School of Public Health.

Vaccine Day began at 12:00 in Sommer Hall with welcome by Ruth Karron, M.D., Director of the Johns Hopkins Vaccine Initiative and an introduction by the Dean of the School of Public Health, Michael Klag, MD, MPH. Dr. Plotkin's keynote address was titled "My Life in Vaccinology". Following the keynote, a faculty panel moderated by Ruth Karron discussed the future of global vaccine research. The faculty panel included Kenrad Nelson, MD, Orin Levine, PhD, and Anna Durbin, MD.

Photo of Orin Levine and Anna Durbin on the faculty panel — Orin Levine and Anna Durbin on the faculty panel

Photo of Dr. Plotkin responds to a question from the audience — Dr. Plotkin responds to a question from the audience

Photo of Kate O'Brien addressing Dr. Plotkin — *Kate O'Brien addresses Dr. Plotkin*

Photo of Kenrad Nelson, Anna Durbin, Stanley Plotkin, Ruth Karron, Orin Levine — (l-r) Kenrad Nelson, Anna Durbin, Stanley Plotkin, Ruth Karron, Orin Levine

Associated Videos:

Following the presentation and panel discussion, Vaccine Day moved to Feinstone Hall for the faculty, staff and student poster session and reception. 27 posters were submitted by students, faculty and staff for Vaccine Day 2010, showcasing work from four departments. The posters highlighted the breadth of vaccine research being conducted at the School, and described pre-clinical studies, phase I and II clinical trials, cost effectiveness studies, policy analysis, and implementation studies. 13 posters submitted were eligible for the student poster contest. Prizes were awarded for the three most outstanding student posters:

First Place Cailin Deal: Development of a Multivalent ‘Universal’ Influenza Vaccine by Utilizing Capsid Display Recombinant Adenoviruses Expressing Highly Conserved Epitopes of M2 and Hemagglutinin
Second Place Andrea Feller: Malnutrition among Children Enrolled in a Clinical Trial with the Pentavalent Rotavirus Vaccine (PRV), RotaTeq™, in Bangladesh
Third Place Erin N Lalime: Primary Differentiated Tracheal Epithelial Cell Cultures Derived from Rhesus Macaques Support Influenza A Virus Infection.